An interventional study of 0.4 ml/kg of 0.5% bupivacaine in Pain, Postoperative, sponsored by King Hussein Cancer Center. Completed at 1 site in Jordan. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-11-14.
Sponsored by King Hussein Cancer Center · Not applicable, Interventional, and Treatment
This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).
This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS). Adult patients scheduled for elective VATS who meet the eligibility criteria will be randomized to either Arm:
Arm 1: General anesthesia with TPVB;
Arm 2: General anesthesia alone (control group).
Primary Outcome: to assess Opioid requirement in the PACU
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's enrollment of 81 is close to the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →King Hussein Cancer Center is the lead sponsor of 23 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
Drug: 0.4 ml/kg of 0.5% bupivacaine
General anesthesia SOC alone
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
Opioid requirement in the PACU
Opioid requirement in the PACU, recorded as "yes" or "no."
Time frame: Opioid requirement assessed at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)
Pain intensity measured by Numeric Rating Scale -NRS
Pain intensity measured by Numeric Rating Scale- NRS at several time points, Range: 0 (no pain) to 10 (worst imaginable pain), Interpretation: Higher scores indicate worse pain intensity
Time frame: Pain intensity measured using the Numeric Rating Scale (NRS) at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King Hussein Cancer Center